Volumetric changes and clinical trajectories in Parkinson's disease: a prospective multicentric study

被引:2
|
作者
Marques, Ana [1 ,2 ,3 ,53 ]
Macias, Elise [1 ,2 ,3 ]
Pereira, Bruno [4 ]
Durand, Elodie [1 ,2 ,3 ]
Chassain, Carine [1 ,2 ,3 ]
Vidal, Tiphaine [1 ,2 ,3 ]
Defebvre, Luc [5 ,6 ]
Carriere, Nicolas [5 ,6 ]
Fraix, Valerie [7 ,8 ]
Moro, Elena [7 ,8 ]
Thobois, Stephane [8 ,9 ,10 ,11 ]
Metereau, Elise [8 ,9 ,10 ,11 ]
Mangone, Graziella [12 ,13 ,14 ,15 ]
Vidailhet, Marie [12 ,13 ,14 ,15 ]
Corvol, Jean-Christophe [12 ,13 ,14 ,15 ]
Lehericy, Stephane [13 ,49 ,50 ,51 ,52 ]
de Champfleur, Nicolas Menjot [16 ,17 ]
Geny, Christian [18 ,19 ]
Spampinato, Umberto [20 ,21 ,22 ]
Meissner, Wassilios G. [20 ,21 ,23 ,24 ,54 ]
Frismand, Solene [25 ,26 ]
Schmitt, Emmanuelle [27 ]
de Maindreville, Anne Doe [28 ,29 ]
Portefaix, Christophe [30 ,31 ]
Remy, Philippe [32 ,33 ,34 ,35 ,36 ]
Fenelon, Gilles [32 ,33 ,34 ,35 ,36 ]
Houeto, Jean Luc [37 ,38 ,39 ,55 ]
Colin, Olivier [37 ,40 ,41 ]
Rascol, Olivier [42 ,43 ,44 ,45 ]
Peran, Patrice [46 ]
Bonny, Jean-Marie [47 ,48 ]
Fantini, Maria Livia [1 ,2 ,3 ]
Durif, Franck [1 ,2 ,3 ]
机构
[1] Univ Clermont Auvergne, Inst Pascal, CNRS, Clermont Auvergne INP,IGCNC, Clermont Ferrand, France
[2] Clermont Ferrand Univ Hosp, Neurol Dept, Clermont Ferrand, France
[3] Clermont Ferrand Univ Hosp, NS PARK FCRIN Network, Clermont Ferrand, France
[4] Clermont Ferrand Univ Hosp, Biostat Unit DRCI, Clermont Ferrand, France
[5] Univ Lille, Dept Movement Disorder, Inserm 1172, Lille, France
[6] Univ Lille, NS PARK FCRIN Network, Inserm 1172, Lille, France
[7] Univ Grenoble Alpes, Grenoble Inst Neurosci, Serv Neurol, CHU Grenoble, Grenoble, France
[8] NS PARK FCRIN Network, Grenoble, France
[9] CNRS, Inst Sci Cognit Marc Jeannerod, UMR 5229, CNRS, Lyon, France
[10] Univ Claude Bernard Lyon 1, Lyon, France
[11] Hop Neurol & Neurochirurg P Wertheimer, Hosp Civils Lyon, Serv Neurol C, Lyon, France
[12] Sorbonne Univ, Dept Neurol, Paris, France
[13] Sorbonne Univ, NS PARK FCRIN Network, Paris, France
[14] AP HP, Inst Cerveau ICM, Paris, France
[15] Hop La Pitie Salpetriere, CNRS 7225, CIC Neurosci, Inserm 1127, Paris, France
[16] Montpellier Univ Hosp Ctr, Gui de Chauliac Hosp, Dept Neuroradiol, Montpellier, France
[17] CHRU Montpellier, Inst Imagerie Fonct Humaine, I2FH, Hop Gui de Chauliac, Montpellier, France
[18] Montpellier Univ, Montpellier Univ Hosp, Dept Geriatr, Montpellier, France
[19] Montpellier Univ, Montpellier Univ Hosp, NS PARK FCRIN Network, Montpellier, France
[20] CHU Bordeaux, Serv Neurol Malad Neurodegenerat, F-33000 Bordeaux, France
[21] CHU Bordeaux, NS PARK FCRIN Network, F-33000 Bordeaux, France
[22] Univ Bordeaux, Team P3TN, INCIA UMR 5287, CNRS, Bordeaux, France
[23] Univ Bordeaux, CNRS, IMN, UMR 5293, F-33000 Bordeaux, Bordeaux, France
[24] Univ Otago, Dept Med, Christchurch, New Zealand
[25] Nancy Univ Hosp Ctr, Dept Neurol, Nancy, France
[26] Nancy Univ Hosp Ctr, NS PARK FCRIN Network, Nancy, France
[27] Nancy Univ Hosp Ctr, Dept Neuroradiol, Nancy, France
[28] Hop Maison Blanche, Dept Neurol, Reims, France
[29] Hop Maison Blanche, NS PARK FCRIN Network, Reims, France
[30] Hop Maison Blanche, Dept Radiol, Reims, France
[31] Univ Reims, CReSTIC Lab, Reims, France
[32] CHU Henri Mondor, Ctr Expert Parkinson, Creteil, France
[33] CHU Henri Mondor, NS PARK FCRIN Network, Creteil, France
[34] Univ Paris Est Creteil, AP HP, Creteil, France
[35] Univ Paris Est Creteil, Fac Sante, Equipe Neuropsychol Intervent, INSERM IMRB, Creteil, France
[36] Paris Sorbonne Univ, Ecole Normale Super, Creteil, France
[37] Univ Poitiers, Ctr Invest Clin CIC1402, INSERM, CHU Poitiers, Poitiers, France
[38] Serv Neurol, Poitiers, France
[39] NS PARK FCRIN Network, Poitiers, France
[40] CH Brive la Gaillarde, Serv Neurol, Poitiers, France
[41] CH Brive la Gaillarde, NS PARK FCRIN Network, Poitiers, France
[42] CHU Toulouse, Ctr Expert Parkinson, Dept Pharmacol Clin, INSERM,Ctr Invest Clin CIC 1436,UMR 1214 TONIC,Ne, Toulouse, France
[43] CHU Toulouse, Dept Neurosci, Ctr Expert Parkinson, INSERM,Ctr Invest Clin CIC 1436,UMR 1214 TONIC,Ne, Toulouse, France
[44] CHU Toulouse, NS PARK FCRIN Network, INSERM, Toulouse, France
[45] Univ Toulouse 3, Toulouse, France
[46] Univ Toulouse, Toulouse NeuroImaging Ctr, ToNIC, INSERM,UPS, Toulouse, France
[47] INRAE, UR QuaPA, F-63122 St Genes Champanelle, France
[48] INRAE, AgroResonance, Nucl Magnet Resonance Facil Agron Food & Hlth, F-2018 St Genes Champanelle, France
[49] Sorbonne Univ, Dept Neuroradiol, Paris, France
[50] AP HP, Inst Cerveau ICM, Paris, France
关键词
Parkinson's disease; Volumetric changes; Brain atrophy; Clinical progression; Longitudinal study; RATING-SCALE; MATTER CHANGES; ATROPHY; PROGRESSION; VALIDATION; GAIT;
D O I
10.1007/s00415-023-11947-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundLongitudinal measures of structural brain changes using MRI in relation to clinical features and progression patterns in PD have been assessed in previous studies, but few were conducted in well-defined and large cohorts, including prospective clinical assessments of both motor and non-motor symptoms.ObjectiveWe aimed to identify brain volumetric changes characterizing PD patients, and determine whether regional brain volumetric characteristics at baseline can predict motor, psycho-behavioral and cognitive evolution at one year in a prospective cohort of PD patients.MethodsIn this multicentric 1 year longitudinal study, PD patients and healthy controls from the MPI-R2* cohort were assessed for demographical, clinical and brain volumetric characteristics. Distinct subgroups of PD patients according to motor, cognitive and psycho-behavioral evolution were identified at the end of follow-up.ResultsOne hundred and fifty PD patients and 73 control subjects were included in our analysis. Over one year, there was no significant difference in volume variations between PD and control subjects, regardless of the brain region considered. However, we observed a reduction in posterior cingulate cortex volume at baseline in PD patients with motor deterioration at one year (p = 0.017). We also observed a bilateral reduction of the volume of the amygdala (p = 0.015 and p = 0.041) and hippocampus (p = 0.015 and p = 0.053) at baseline in patients with psycho-behavioral deterioration, regardless of age, dopaminergic treatment and center.ConclusionBrain volumetric characteristics at baseline may predict clinical trajectories at 1 year in PD as posterior cingulate cortex atrophy was associated with motor decline, while amygdala and hippocampus atrophy were associated with psycho-behavioral decline.
引用
收藏
页码:6033 / 6043
页数:11
相关论文
共 50 条
  • [21] Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal Study
    Lee, Pei-Chen
    Artaud, Fanny
    Cormier-Dequaire, Florence
    Rascol, Olivier
    Durif, Franck
    Derkinderen, Pascal
    Marques, Ana-Raquel
    Bourdain, Frederic
    Brandel, Jean-Philippe
    Pico, Fernando
    Lacomblez, Lucette
    Bonnet, Cecilia
    Brefel-Courbon, Christine
    Ory-Magne, Fabienne
    Grabli, David
    Klebe, Stephan
    Mangone, Graziella
    You, Hana
    Mesnage, Valerie
    Brice, Alexis
    Vidailhet, Marie
    Corvol, Jean-Christophe
    Elbaz, Alexis
    MOVEMENT DISORDERS, 2019, 34 (11) : 1663 - 1671
  • [22] Brain Volumetric Correlates of Memory in Early Parkinson's Disease
    Ellfolk, Ulla
    Joutsa, Juho
    Rinne, Juha O.
    Parkkola, Riitta
    Jokinen, Pekka
    Karrasch, Mira
    JOURNAL OF PARKINSONS DISEASE, 2013, 3 (04) : 593 - 601
  • [23] Clinical Review of Smartphone Applications in Parkinson's Disease
    Tripathi, Susmit
    Malhotra, Ashwin
    Qazi, Murtaza
    Chou, Jingyuan
    Wang, Fei
    Barkan, Samantha
    Hellmers, Natalie
    Henchcliffe, Claire
    Sarva, Harini
    NEUROLOGIST, 2022, 27 (04) : 183 - 193
  • [24] A prospective study of alcoholism and the risk of Parkinson's disease
    Hernán, MA
    Logroscino, G
    Rodriguez, LAG
    JOURNAL OF NEUROLOGY, 2004, 251 (Suppl 7) : 14 - 17
  • [25] A prospective study of alcoholism and the risk of Parkinson’s disease
    Miguel A. Hernán
    Giancarlo Logroscino
    Luis A. García Rodríguez
    Journal of Neurology, 2004, 251 : vii14 - vii17
  • [26] Tolerability of paroxetine in Parkinson's disease: A prospective study
    Tesei, S
    Antonini, A
    Canesi, M
    Zecchinelli, A
    Mariani, CB
    Pezzoli, G
    MOVEMENT DISORDERS, 2000, 15 (05) : 986 - 989
  • [27] Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study
    Di Fonzo, Alessio
    Percetti, Marco
    Monfrini, Edoardo
    Palmieri, Ilaria
    Albanese, Alberto
    Avenali, Micol
    Bartoletti-Stella, Anna
    Blandini, Fabio
    Brescia, Gloria
    Calandra-Buonaura, Giovanna
    Campopiano, Rosa
    Capellari, Sabina
    Colangelo, Isabel
    Comi, Giacomo Pietro
    Cuconato, Giada
    Ferese, Rosangela
    Galandra, Caterina
    Gambardella, Stefano
    Garavaglia, Barbara
    Gaudio, Andrea
    Giardina, Emiliano
    Invernizzi, Federica
    Mandich, Paola
    Mineri, Rossana
    Panteghini, Celeste
    Reale, Chiara
    Trevisan, Lucia
    Zampatti, Stefania
    Cortelli, Pietro
    Valente, Enza Maria
    MOVEMENT DISORDERS, 2023, 38 (12) : 2241 - 2248
  • [28] Prospective study of hallucinations and delusions in Parkinson's disease
    Holroyd, S
    Currie, L
    Wooten, GF
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (06) : 734 - 738
  • [29] Deep brain stimulation in Parkinson's disease: A multicentric, long-term, observational pilot study
    Scelzo, Emma
    Beghi, Ettore
    Rosa, Manuela
    Angrisano, Serena
    Antonini, Angelo
    Bagella, Caterina
    Bianchi, Elisa
    Caputo, Elena
    Lena, Francesco
    Lopiano, Leonardo
    Marcante, Andrea
    Marceglia, Sara
    Massaro, Francesco
    Modugno, Nicola
    Pacchetti, Claudio
    Pilleri, Manuela
    Pozzi, Nicolo Gabriele
    Romito, Luigi Michele
    Sandlli, Marco
    Tamma, Filippo
    Weis, Luca
    Zibetti, Maurizio
    Priori, Alberto
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [30] Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease
    Baba, Toru
    Hosokai, Yoshiyuki
    Nishio, Yoshiyuki
    Kikuchi, Akio
    Hirayama, Kazumi
    Suzuki, Kyoko
    Hasegawa, Takafumi
    Aoki, Masashi
    Takeda, Atsushi
    Mori, Etsuro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 372 : 288 - 293